AnalystsMichael FreemanMichael Freeman's Stock Forecasts
AnalystsMichael Freeman
Sectors:
Analyst Ranking
Top 36%
#1817 out of 5115 analysts
Average Return
+50.18%
Win Rate
80%4 out of 5
Risk vs Reward
Poor
Good
Michael Freeman's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avidity Biosciences IncRNA | +123.56% | $32.01 | $71.56 | 2025-06-11 - 2025-11-26 | Strong Buy |
Disc Medicine IncIRON | +84.33% | $50.86 | $93.75 | 2025-06-11 - 2025-11-26 | Strong Buy |
Dyne Therapeutics IncDYN | +45.30% | $14.57 | $21.17 | 2025-06-11 - 2025-11-26 | Buy |
Wave Life Sciences LtdWVE | +6.68% | $7.19 | $7.67 | 2025-06-11 - 2025-11-26 | Buy |
Michael Freeman Analyst Color
Get additional color on Michael Freeman's coverage of popular stocks
Michael Freeman's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Wave Life Sciences LtdWVE | 1 | Buy | $14.00 | +82.53% | Assumes | 6 months ago |
Tectonic Therapeutic IncTECX | 1 | Buy | $76.00 | +255.31% | Reinstates | 6 months ago |
Dyne Therapeutics IncDYN | 1 | Buy | $37.00 | +74.78% | Assumes | 6 months ago |
Disc Medicine IncIRON | 1 | Strong Buy | $89.00 | -5.07% | Reinstates | 6 months ago |
Avidity Biosciences IncRNA | 1 | Strong Buy | $65.00 | -9.17% | Initiates Coverage On | 6 months ago |
Bausch Health Companies IncBHC | 1 | Hold | $8.00 | N/A | Initiates Coverage On | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.